Parnassus Investments - Parnassus Endeavor Fund 13F Activity & Position Changes (Q4 2022)
According to the SEC 13F filed on Jan 30, 2023, the Parnassus Endeavor Fund portfolio showed several notable changes in holdings as of quarter-end Dec 31, 2022. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q4 2022, the filing reported:
New Buys - Advanced Micro Devices, Inc., Amazon.com, Inc., Ares Management Corporation, Astrazeneca PLC, Boston Scientific Corporation, and 16 more
Increases - Accenture plc, Autodesk, Inc., Align Technology, Inc., Applied Materials, Inc., ANSYS, Inc., and 22 more
Reductions - Agilent Technologies, Inc., Apple Inc., Abbott Laboratories, Adobe Inc., American Tower Corporation (REI, and 50 more
Complete Exits - Alnylam Pharmaceuticals, Inc., Cable One, Inc., Americold Realty Trust, Inc., Discover Financial Services, First Horizon Corporation, and 4 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q4 2022
|
A
Agilent Technologies, Inc.
|
Sell |
-311,855
|
|
Q4 2022
|
AAPL
Apple Inc.
|
Sell |
-19,603
|
|
Q4 2022
|
ABT
Abbott Laboratories
|
Sell |
-2,006,873
|
|
Q4 2022
|
ACN
Accenture plc
|
Buy |
+115,466
|
|
Q4 2022
|
ADBE
Adobe Inc.
|
Sell |
-978,869
|
|
Q4 2022
|
ADSK
Autodesk, Inc.
|
Buy |
+32,430
|
|
Q4 2022
|
ALGN
Align Technology, Inc.
|
Buy |
+421,598
|
|
Q4 2022
|
ALNY
Alnylam Pharmaceuticals, Inc.
|
Sell - Position Exit |
-25,970
|
|
Q4 2022
|
AMAT
Applied Materials, Inc.
|
Buy |
+3,373,082
|
|
Q4 2022
|
AMD
Advanced Micro Devices, Inc.
|
Buy - Position Entry |
+3,294
|
|
Q4 2022
|
AMT
American Tower Corporation (REI
|
Sell |
-12,637
|
|
Q4 2022
|
AMZN
Amazon.com, Inc.
|
Buy - Position Entry |
+7,636
|
|
Q4 2022
|
ANSS
ANSYS, Inc.
|
Buy |
+233,659
|
|
Q4 2022
|
ARES
Ares Management Corporation
|
Buy - Position Entry |
+3,514
|
|
Q4 2022
|
AVTR
Avantor, Inc.
|
Sell |
-489,974
|
|
Q4 2022
|
AZN
Astrazeneca PLC
|
Buy - Position Entry |
+3,905
|
|
Q4 2022
|
BAC
Bank of America Corporation
|
Buy |
+25,077,300
|
|
Q4 2022
|
BALL
Ball Corporation
|
Buy |
+1,770,734
|
|
Q4 2022
|
BDX
Becton, Dickinson and Company
|
Sell |
-2,539,375
|
|
Q4 2022
|
BIIB
Biogen Inc.
|
Sell |
-41,943
|
|
Q4 2022
|
BMRN
BioMarin Pharmaceutical Inc.
|
Sell |
-227,551
|
|
Q4 2022
|
BR
Broadridge Financial Solutions,
|
Sell |
-257,900
|
|
Q4 2022
|
BSX
Boston Scientific Corporation
|
Buy - Position Entry |
+5,157
|
|
Q4 2022
|
C
Citigroup, Inc.
|
Buy - Position Entry |
+1,502,553
|
|
Q4 2022
|
CABO
Cable One, Inc.
|
Sell - Position Exit |
-83,212
|
|
Q4 2022
|
CBOE
Cboe Global Markets, Inc.
|
Sell |
-529,900
|
|
Q4 2022
|
CDNS
Cadence Design Systems, Inc.
|
Sell |
-20,554
|
|
Q4 2022
|
CHRW
C.H. Robinson Worldwide, Inc.
|
Sell |
-131,796
|
|
Q4 2022
|
CL
Colgate-Palmolive Company
|
Buy - Position Entry |
+2,697
|
|
Q4 2022
|
CMCSA
Comcast Corporation
|
Sell |
-26,172,696
|
Page 1 of 4